Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL925361 | 1.00 | BLM (0.62) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL935526 | 0.82 | BLM (0.50) | BLMLMNAACE2PTPN1MEN1 | |
| Squalane SCHEMBL28338533 | 0.81 | BLM (0.69) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL27458546 | 0.78 | BLM (0.60) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL28238013 | 0.78 | BLM (0.60) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL28455451 | 0.78 | BLM (0.60) | BLMLMNAACE2PTPN1MEN1 | |
| Acetic Acid SCHEMBL20972332 | 0.78 | BLM (0.71) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL28455377 | 0.77 | BLM (0.58) | BLMLMNAACE2PTPN1MEN1 | |
| SCHEMBL14661585 | 0.77 | CA2 (0.50) | ACE2SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL11600716 | 0.77 | BLM (1.00) | BLMLMNAACE2PTPN1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008124749-A1 | ACRIDINIUM PHENYL ESTERS USEFUL IN THE ANALYSIS OF BIOLOGICAL SAMPLES | ABBOTT LABORATORIES (US) | 2008-10-16 | — | — | WO | claimed |
| US-20080248493-A1 | ACRIDINIUM PHENYL ESTERS USEFUL IN THE ANALYSIS OF BIOLOGICAL SAMPLES | ABBOTT LABORATORIES | 2008-10-09 | — | — | US | claimed |
| EP-1578317-A2 | DELIVERY OF PEROXIDE-GENERATING ENZYMES TO THE VAGINAL TRACT | Kimberly-Clark Worldwide, Inc. (US) | 2005-09-28 | — | — | EP | claimed |
| WO-2004060272-A2 | DELIVERY OF PEROXIDE-GENERATING ENZYMES TO THE VAGINAL TRACT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-07-22 | — | — | WO | claimed |
| US-20040126369-A1 | Delivery of peroxide-generating enzymes to the vaginal tract | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-07-01 | — | — | US | claimed |
| US-10641768-B2 | Methods and kits for decreasing interferences from leukocytes in specific binding assays | ABBOTT JAPAN CO. LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-9120862-B2 | Antibodies relating to PIVKA-II and uses thereof | ABBOTT LABORATORIES (US) | 2015-09-01 | — | — | US | disclosed |
| US-8835120-B2 | Assay for cardiac troponin-T (cTnT) | ABBOTT LABORATORIES (US) | 2014-09-16 | — | — | US | disclosed |
| US-8652788-B2 | Assay for diagnosis of cardiac myocyte damage | ABBOTT LABORATORIES (US) | 2014-02-18 | — | — | US | disclosed |
| US-8574858-B2 | Autoantibody enhanced immunoassays and kits | ABBOTT LABORATORIES (US) | 2013-11-05 | — | — | US | disclosed |
| US-20130029353-A1 | AUTOANTIBODY ENHANCED IMMUNOASSAYS AND KITS | ABBOTT LABORATORIES (US) | 2013-01-31 | — | — | US | disclosed |
| US-20130011826-A1 | METHODS AND KITS FOR DECREASING INTERFERENCES FROM LEUKOCYTES IN SPECIFIC BINDING ASSAYS | ABBOTT LABORATORIES (US) | 2013-01-10 | — | — | US | disclosed |
| EP-1536950-B8 | METHOD FOR ENZYME MEDIATED REMOVAL OF GAS FROM INKS, AND REDUCED GAS INKS | KIMBERLY CLARK CO (US) | 2006-08-16 | — | — | EP | disclosed |
| EP-1536950-B1 | METHOD FOR ENZYME MEDIATED REMOVAL OF GAS FROM INKS, AND REDUCED GAS INKS | KIMBERLY CLARK CO (US) | 2006-05-24 | — | — | EP | disclosed |
| EP-1536950-A1 | METHOD FOR ENZYME MEDIATED REMOVAL OF GAS FROM INKS, AND REDUCED GAS INKS | KIMBERLY-CLARK CORPORATION (US) | 2005-06-08 | — | — | EP | disclosed |
| US-6726754-B2 | DEGASSING INK BY ADDING AT LEAST ONE ENZYME CAPABLE OF CATALYZING PRODUCTION OF REACTION PRODUCT ACCEPTABLE TO INK FORMULATION, USING DONOR SUBSTRATE CONTAINED IN INK UPON EXPOSURE TO GASEOUS ACCEPTOR SUBSTRATE | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-04-27 | — | — | US | disclosed |
| WO-2004028818-A1 | METHOD FOR ENZYME MEDIATED REMOVAL OF GAS FROM INKS, AND REDUCED GAS INKS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-04-08 | — | — | WO | disclosed |
| WO-2004024859-A1 | METHOD FOR ENHANCING CLEANSING VEHICLES AND CLEANSING VEHICLES UTILIZING SUCH METHOD | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-03-25 | — | — | WO | disclosed |
| US-20040055505-A1 | METHOD FOR ENZYME MEDIATED REMOVAL OF GAS FROM INKS, AND REDUCED GAS INKS | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-25 | — | — | US | disclosed |
| US-20040053803-A1 | Method for enhancing cleansing vehicles and cleansing vehicles utilizing such method | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-03-18 | — | — | US | disclosed |